Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 [Phase 2]
An ongoing Phase 2 trial evaluating the WEE1 inhibitor adavosertib (AZD1775) in advanced solid tumors with SETD2 mutations, including clear …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating dual-target CD70/CAIX CAR-NK cells for advanced or metastatic clear cell renal cell carcinoma is curre…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAIX PET/ CT Guided Radiation Therapy in CcRCC. [NA]
This entry reports an ongoing clinical trial evaluating CAIX PET/CT-guided radiation therapy for clear cell renal cell carcinoma, including …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC [Phase 1, Phase 2]
Phase 1b/2 trial evaluating a triple combination of 177Lu-girentuximab, cabozantinib, and nivolumab in treatment-naïve patients with advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 clinical trial evaluating nivolumab and ipilimumab with and without Camu Camu in metastatic renal cell carcinoma, including clear ce…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1]
Phase 1 clinical trial evaluating IB-T101 injection for advanced clear cell renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study [Phase 3]
PDIGREE is a Phase 3 trial evaluating nivolumab plus ipilimumab followed by nivolumab with or without cabozantinib in advanced renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]
Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial [Phase 2]
This update describes a Phase 2 trial to assess the safety and feasibility of Botensilimab and Balstilimab given before surgery for clear ce…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) [Phase 1, Phase 2]
A sponsor-backed Phase 1/2 clinical trial evaluates the combination of palbociclib and sasanlimab for advanced clear cell renal cell carcino…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer [Phase 3]
Phase 3 trial evaluating adding tivozanib to pembrolizumab after surgery for kidney cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) [Phase 1]
A first-in-human Phase 1 trial evaluating BMS-986506 in adults with advanced clear cell renal cell carcinoma (ccRCC); recruitment is ongoing…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis [Phase 2]
A Phase 2 neoadjuvant trial evaluating Zanzalintinib plus nivolumab for locally advanced or inoperable clear cell renal cell carcinoma (with…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC [Phase 2]
This is a Phase 2 clinical trial update for Zanzalintinib (XL092) in combination with immunotherapy for advanced or metastatic renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating VSV-IFNβ-NIS in combination with ipilimumab and nivolumab for advanced or metastatic clear cell renal cell carcin…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 randomized trial evaluating the combination of fianlimab and cemiplimab with or without ipilimumab, or ipilimumab plus nivolumab, …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC [Phase 3]
Phase 3 study to assess safety and efficacy of 177Lu-TLX250 in advanced relapsed or recurrent clear cell renal cell carcinoma is currently r…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
An NCI-sponsored clinical trial evaluating Von Hippel-Lindau–associated renal and other urologic malignancies, including manifestations, dia…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors [Phase 1]
A Phase 1 study evaluating AB521 as both a single agent and in combination regimens for clear cell renal cell carcinoma and other solid tumo…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma [Phase 1]
A Phase 1 study of UCL70805F in CD70-positive advanced clear cell renal cell carcinoma is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for a combination of sasanlimab, palbociclib, and axitinib in metastatic renal cell carcinoma; currently recru…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study [Phase 2]
Phase II clinical trial evaluating AK112 (Yiwoxidan Anti) as monotherapy for metastatic clear cell renal cell carcinoma in patients intolera…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…